Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 2176749, 9 pages
https://doi.org/10.1155/2017/2176749
Research Article

Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat

1Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary
2Department of Cardiology, Medical University of Vienna, Vienna, Austria
3Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

Correspondence should be addressed to Anikó Posa; uh.degezs-u.oib@okinap

Received 30 March 2017; Revised 17 May 2017; Accepted 25 May 2017; Published 9 July 2017

Academic Editor: Márcio Carocho

Copyright © 2017 Anikó Posa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. M. Boardman, L. Hartley, A. Eisinga et al., “Hormone therapy for preventing cardiovascular disease in post-menopausal women,” Cochrane Database of Systematic Reviews, vol. 3, article CD002229, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Persky, P. S. Green, L. Stubley et al., “Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro,” Proceedings of the Society for Experimental Biology and Medicine, vol. 223, no. 1, pp. 59–66, 2000. View at Publisher · View at Google Scholar
  3. M. Ozgonul, A. Öge, E. D. Sezer, F. Bayraktar, and E. Y. Sözmen, “The effects of estrogen and raloxifene treatment on antioxidant enzymes in brain and liver of ovarectomized female rats,” Endocrine Research, vol. 29, no. 2, pp. 183–189, 2003. View at Google Scholar
  4. A. Posa, R. Szabó, A. Csonka et al., “Endogenous estrogen-mediated heme oxygenase regulation in experimental menopause,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 429713, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. C. Carr, M. R. McCall, and B. Frei, “Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 7, pp. 1716–1723, 2000. View at Publisher · View at Google Scholar
  6. R. Zhang, M. L. Brennan, X. Fu et al., “Association between myeloperoxidase levels and risk of coronary artery disease,” JAMA, vol. 286, no. 17, pp. 2136–2142, 2001. View at Google Scholar
  7. T. Muka, K. G. Vargas, L. Jaspers et al., “Estrogen receptor beta actions in the female cardiovascular system: a systematic review of animal and human studies,” Maturitas, vol. 86, pp. 28–43, 2016. View at Google Scholar
  8. G. F. Vile, S. Basu-Modak, C. Waltner, and R. M. Tyrrell, “Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 7, pp. 2607–2610, 1994. View at Google Scholar
  9. G. Wang, T. Hamid, R. J. Keith et al., “Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart,” Circulation, vol. 121, no. 17, pp. 1912–1925, 2010. View at Google Scholar
  10. N. K. Idriss, A. D. Blann, and G. Y. Lip, “Hemoxygenase-1 in cardiovascular disease,” Journal of the American College of Cardiology, vol. 52, no. 12, pp. 971–978, 2008. View at Google Scholar
  11. H. J. Duckers, M. Boehm, A. L. True et al., “Heme oxygenase-1 protects against vascular constriction and proliferation,” Nature Medicine, vol. 7, no. 6, pp. 693–698, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Zakhary, S. P. Gaine, J. L. Dinerman, M. Ruat, N. A. Flavahan, and S. H. Snyder, “Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 2, pp. 795–798, 1996. View at Google Scholar
  13. C. M. Weber, B. C. Eke, and M. D. Maines, “Corticosterone regulates heme oxygenase-2 and NO synthase transcription and protein expression in rat brain,” Journal of Neurochemistry, vol. 63, no. 3, pp. 953–962, 1994. View at Google Scholar
  14. W. Tschugguel, F. Stonek, Z. Zhegu et al., “Estrogen increases endothelial carbon monoxide, heme oxygenase 2, and carbon monoxide-derived cGMP by a receptor-mediated system,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3833–3839, 2001. View at Google Scholar
  15. S. Konyalioglu, G. Durmaz, and A. Yalcin, “The potential antioxidant effect of raloxifene treatment: a study on heart, liver and brain cortex of ovariectomized female rats,” Cell Biochemistry and Function, vol. 25, no. 3, pp. 259–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Collins, L. Mosca, M. J. Geiger et al., “Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors,” Circulation, vol. 119, no. 7, pp. 922–930, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Posa, K. Kupai, R. Ménesi et al., “Sexual dimorphism of cardiovascular ischemia susceptibility is mediated by heme oxygenase,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 521563, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Pavo, F. László, É. Morschl et al., “Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats,” European Journal of Pharmacology, vol. 410, no. 1, pp. 101–104, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Nemcsik, É. Morschl, J. Egresits et al., “Raloxifene lowers ischaemia susceptibility by increasing nitric oxide generation in the heart of ovariectomized rats in vivo,” European Journal of Pharmacology, vol. 495, no. 2-3, pp. 179–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. B. J. Whittle, C. Varga, A. Berko et al., “Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase,” British Journal of Pharmacology, vol. 153, no. 5, pp. 983–991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Posa, I. Pavo, and C. Varga, “Heme oxygenase contributes to estradiol and raloxifene-induced vasorelaxation in estrogen deficiency,” International Journal of Cardiology, vol. 189, pp. 252–254, 2015. View at Google Scholar
  22. L. Szalay, T. Shimizu, M. G. Schwacha et al., “Mechanism of salutary effects of estradiol on organ function after trauma-hemorrhage: upregulation of heme oxygenase,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 1, pp. H92–H98, 2005. View at Google Scholar
  23. J. F. Ndisang, W. Zhao, and R. Wang, “Selective regulation of blood pressure by heme oxygenase-1 in hypertension,” Hypertension, vol. 40, no. 3, pp. 315–321, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. F. Yet, A. Pellacani, C. Patterson et al., “Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock,” The Journal of Biological Chemistry, vol. 272, no. 7, pp. 4295–4301, 1997. View at Google Scholar
  25. S. A. Lee, E. Y. Kim, W. K. Jeon et al., “The inhibitory effect of raloxifene on lipopolysaccharide-induced nitric oxide production in RAW264.7 cells is mediated through a ROS/p38 MAPK/CREB pathway to the up-regulation of heme oxygenase-1 independent of estrogen receptor,” Biochimie, vol. 93, no. 2, pp. 168–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Esposito, A. Iacono, G. M. Raso et al., “Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats,” Endocrinology, vol. 146, no. 8, pp. 3301–3308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Ikeno, H. Minato, C. Kohayakawa, and J. I. Tsuji, “Effect of OS-0544, a selective estrogen receptor modulator, on endothelial function and increased sympathetic activity in ovariectomized rats,” Vascular Pharmacology, vol. 50, no. 1-2, pp. 40–44, 2009. View at Google Scholar
  28. C. P. Weiner, I. Lizasoain, S. A. Baylis, R. G. Knowles, I. G. Charles, and S. Moncada, “Induction of calcium-dependent nitric oxide synthases by sex hormones,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 11, pp. 5212–5216, 1994. View at Google Scholar
  29. K. Kawamura, K. Ishikawa, Y. Wada et al., “Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 1, pp. 155–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Thorup, C. L. Jones, S. S. Gross, L. C. Moore, and M. S. Goligorsky, “Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS,” The American Journal of Physiology, vol. 277, Part 2, no. 6, pp. F882–F889, 1999. View at Google Scholar
  31. J. J. Andresen, N. I. Shafi, W. Durante, and R. M. Bryan, “Effects of carbon monoxide and heme oxygenase inhibitors in cerebral vessels of rats and mice,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 291, no. 1, pp. H223–H230, 2006. View at Google Scholar
  32. F. Kozma, R. A. Johnson, F. Zhang, C. Yu, X. Tong, and A. Nasjletti, “Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels,” The American Journal of Physiology, vol. 276, Part 2, no. 4, pp. R1087–R1094, 1999. View at Google Scholar
  33. A. W. Jones, W. Durante, and R. J. Korthuis, “Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation,” The Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 1, pp. 85–91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Bak, L. Szendrei, T. Turoczi et al., “Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium,” The FASEB Journal, vol. 17, no. 14, pp. 2133–2135, 2003. View at Google Scholar
  35. R. Motterlini, A. Gonzales, R. Foresti, J. E. Clark, C. J. Green, and R. M. Winslow, “Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo,” Circulation Research, vol. 83, no. 5, pp. 568–577, 1998. View at Publisher · View at Google Scholar
  36. Y. H. Chen, S. F. Yet, and M. A. Perrella, “Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function,” Experimental Biology and Medicine, vol. 228, no. 5, pp. 447–453, 2003. View at Publisher · View at Google Scholar
  37. H. E. Sabaawy, F. Zhang, X. Nguyen et al., “Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats,” Hypertension, vol. 38, no. 2, pp. 210–215, 2001. View at Publisher · View at Google Scholar
  38. T. Vera, S. Kelsen, L. L. Yanes, J. F. Reckelhoff, and D. E. Stec, “HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 292, no. 4, pp. R1472–R1478, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Vera, S. Kelsen, and D. E. Stec, “Kidney-specific induction of heme oxygenase-1 prevents angiotensin II hypertension,” Hypertension, vol. 52, no. 4, pp. 660–665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. M. T. Chung, P. Y. Cheng, K. K. Lam et al., “Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats,” Menopause, vol. 17, no. 1, pp. 127–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Aksakal, N. Akaras, I. H. Tanboga et al., “Relationship between oxidative stress and cardiomyopathic changes in ovariectomized rats,” Cardiology, vol. 119, no. 4, pp. 235–241, 2011. View at Google Scholar
  42. J. P. Eiserich, S. Baldus, M. L. Brennan et al., “Myeloperoxidase, a leukocyte-derived vascular NO oxidase,” Science, vol. 296, no. 5577, pp. 2391–2394, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Posa, N. Pavo, R. Hemetsberger et al., “Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs,” Thrombosis and Haemostasis, vol. 103, no. 2, pp. 450–460, 2010. View at Google Scholar